A detailed history of Kestra Private Wealth Services, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Kestra Private Wealth Services, LLC holds 32,709 shares of IBRX stock, worth $79,155. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,709
Previous 26,635 22.8%
Holding current value
$79,155
Previous $168,000 27.98%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.32 - $6.7 $20,165 - $40,695
6,074 Added 22.8%
32,709 $121,000
Q2 2024

Aug 12, 2024

BUY
$4.82 - $9.15 $128,380 - $243,710
26,635 New
26,635 $168,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $969M
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Kestra Private Wealth Services, LLC Portfolio

Follow Kestra Private Wealth Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.